$AOSL

Alpha and Omega Semiconductor (NASDAQ:AOSL) Hits New 12

Alpha and Omega Semiconductor (AOSL) hit a new 52-week high on Wednesday, trading up to $51.14 and last at $48.57 versus a prior close of $47.89 on volume of 383,610 shares. The company reported May 6 quarterly EPS of -$0.28 (vs -$0.34 expected) on revenue of $163.79M (vs $160.07M). Analysts’ consensus is “Hold” with an average target of $30.50.

Original reporting
Published May 27, 2026, 4:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 27, 2026, 4:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Alpha and Omega Semiconductor (NASDAQ:AOSL) Hits New 12 — source image
Decision brief

The 30-second read

$AOSLBullishMed
01

Why it matters

The immediate tradable catalyst is the May 6 earnings beat paired with a new 52-week high; however, persistent losses and mixed analyst ratings suggest elevated volatility rather than a clean trend reversal.

02

Market read

Traders may treat the EPS beat as a near-term momentum trigger, but should monitor for profit-taking given ongoing losses and notable insider selling.

03

What to watch

Insiders sold shares under Rule 10b5-1 in the last 90 days (59,860 shares worth $1.913M), which can cap upside even after a beat.

Relevance 9/10Timing: Immediate—stock is already at a new 52-week high following the May 6 earnings print; momentum traders may act on continuation or mean-reversion.

Background

AOSL designs and supplies power semiconductor components for power management applications; the article focuses on a post-earnings price breakout and analyst/insider activity.

Company-level read

Ticker impact

$AOSLBullishMedium confidence
Context

AOSL hit a new 52-week high after reporting May 6 quarterly EPS of -$0.28, beating the -$0.34 consensus and revenue of $163.79M.

Expected impact

Likely bullish bias for the next session(s) as traders price in the EPS beat; follow-through depends on guidance/next-quarter expectations not provided here.

Evidence & confidence

The article provides a concrete earnings beat and the stock’s breakout to a 52-week high, but lacks forward guidance details; insider selling and mixed analyst targets temper conviction.

Market effects

Power semiconductor names may see mild sentiment lift when a peer shows an earnings beat, but this is company-specific without broader sector catalysts.

Primarily US small/mid-cap semiconductor sentiment; no explicit regional macro driver cited.

No direct global supply-chain or geopolitical catalyst mentioned; relevance is limited to AOSL’s fundamentals and positioning.

Counterpoint

The earnings beat may be insufficient to reverse the longer-term downtrend given negative net margin, negative ROE, and a consensus “Hold” with a wide range of targets.

Key entities

  • Alpha and Omega Semiconductor Limited

    NASDAQ-listed power semiconductor supplier; reported May 6 quarterly EPS -$0.28 vs -$0.34 consensus and shares reached a new 52-week high.

  • Bing Xue

    EVP sold 2,408 shares at $21.92 on March 16 under SEC-disclosed transaction.

  • Yifan Liang

    CFO sold 26,517 shares at $30.57 on April 14 under a pre-arranged Rule 10b5-1 plan.

Related articles

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.

$KOPMed

Koppers Q2 Earnings Call Highlights

Koppers (NYSE:KOP) reported Q2 updates on capital spending of about $24M, shareholder returns of $47M, and debt reduction of $22M in the first half. Liquidity was $390M with net debt of $857M and net leverage at 3.5x. The board raised its dividend to $0.09/share. KOP kept 2026 sales guidance at $1.9B-$2.0B but cut adjusted EBITDA to $240M-$250M and EPS to $3.80-$4.20.

$KNTKMed

Kinetik Q2 Earnings Call Highlights

Kinetik (NYSE:KNTK) Q2 earnings call said Waha pricing normalization and faster curtailment return, higher WTI and liquids assumptions, and system operating improvements supported a revised outlook. It raised 2026 capex to about $560M, expects Q3 Adjusted EBITDA $260M-$270M and Q4 $270M-$280M, and lifted 2026 volume growth to mid- to high-single digits.

$KRMNMed

Karman Q2 Earnings Call Highlights

Karman (NYSE:KRMN) reaffirmed full-year organic growth of 25% or more after Q2 organic revenue rose 24.4% YoY. Management expects second-half revenue to rise sequentially, with Tactical Missiles and IDS, Hypersonics, and Space and Launch as key drivers. Karman converted one contingent supply agreement into a firm contract and plans capacity expansion, plus a £70m ($94m) Walker Precision acquisition.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.